Search

Author/Creator Andreani, Giacomo

1. Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms. Issue 18 (13th August 2020)

Authors:
Petiti, Jessica; Lo Iacono, Marco; Rosso, Valentina; Andreani, Giacomo; Jovanovski, Aleksandar; Podestà, Marina; Lame, Dorela; Gobbi, Marco De; Fava, Carmen; Saglio, Giuseppe; Frassoni, Francesco; Cilloni, Daniela
Journal:
Journal of cellular and molecular medicine
Issue:
Volume 24:Issue 18(2020)
Page Start:
10978
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia. Issue 13 (10th November 2019)

Authors:
Dragani, Matteo; Rege-Cambrin, Giovanna; Ferrero, Dario; Abruzzese, Elisabetta; Pregno, Patrizia; Elena, Chiara; Cedrone, Michele; Santoro, Marco; Andreani, Giacomo; Saglio, Giuseppe; Fava, Carmen
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 13(2019)
Page Start:
3330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantation. Issue 2 (29th November 2018)

Authors:
Andreani, Giacomo; Dragani, Matteo; Serra, Anna; Nicoli, Paolo; De Gobbi, Marco; Cilloni, Daniela
Journal:
American journal of hematology
Issue:
Volume 94:Issue 2(2019:Feb.)
Page Start:
E48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗